期刊文献+

地特胰岛素联合口服降糖药对老年2型糖尿病50例的治疗体会 被引量:2

下载PDF
导出
摘要 将100例老年2型糖尿病患者随机分为观察组和对照组各50例。两组均口服降糖药,观察组给予地特胰岛素注射,对照组给予甘精胰岛素注射。比较两组患者血糖变化、体重变化、用量等指标。结果观察组空腹血糖7.11±0.33mmol/L,体重增加2.11±0.78kg,用药计量0.4U/kg;对照组空腹血糖7.09±0.61mmol/L,体重增加6.44±1.12kg,用药计量0.8U/kg。地特胰岛素结合口服降糖药可以维持血糖稳定、维持体重、低血糖发生次数也低,值得推广。
作者 赵杰
机构地区 贵航安顺
出处 《现代诊断与治疗》 CAS 2013年第12期2706-2706,共1页 Modern Diagnosis and Treatment
  • 相关文献

参考文献4

二级参考文献13

共引文献46

同被引文献26

  • 1Huang Z, Wan X, Liu J, et al.Short-term continuous subcutaneous insulin infusion combined with insulin sensitizers rosiglitazone, metformin, or antioxidant tx-lipoic acid in patients with newly diagnosed type 2 diabetes mellitus[J].Diabetes Technol Ther,2013,15(10):859-869.
  • 2Wang JS, Huang CN, Hung YJ, et al.Acarbose plus metformin fixed-dose combination outperforms acarbose monotherapy for type 2 diabetes[J].Diabetes Res Clin Pract, 2013,102(1):16-24.
  • 3Nakhaee A, Sanjari M.Evaluation of effect of acarbose consumption on weight losing in non-diabetic overweight or obese patients in Kerman[J].J Res Med Sci. 2013,18(5):391- 394.
  • 4Zheng F, Yin X, Lu W, et al.Improved post-prandial ghrelin response by nateglinide or acarbose therapy contributes to glucose stability in Type 2 diabetic patients[J].J Endocrinol Invest,2013,36(7):489-496.
  • 5Zhu Q, Tong Y, Wu T, et al. Comparison of the hypoglycemic effect of acarbose monotherapy in patients with type 2 diabetes mellitus consuming an Eastern or Western diet: a systematic meta-analysis[J].Clin Ther,2013,35(6):880-899.
  • 6Smith-Marsh D.Pharmacological strategies for preventing type 2 diabetes in patients with impaired glucose tolerance[J].Drugs Today(Barc),2013,49(8):499-507.
  • 7Shihabi AR, Moussa EM, Sobierajska H, et al.An observational study of acarbose treatment in patients with type 2 diabetes from the Middle East and Morocco[J]. Diabetes Metab Syndr Obes,2013,9(6):141-150.
  • 8Yang G, Li C, Gong Y,A prospective, randomized, open- label study comparing the efficacy and safety of preprandialand prandial insulin in combination with acarbose in elderly, insulin-requiring patients with type 2 diabetes mellitus [J].Diabetes Technol Ther,2013,15(6):513-519.
  • 9Zhou J, Li H, Zhang X, Nateglinide and acarbose are comparably effective reducers of postprandial glycemic excursions in chinese antihyperglycemic agent-naive subjects with type 2 diabetes[J].Diabetes Technol Ther,2013,15(6):481-488.
  • 10Wu QL, Liu YP, Lu JM, et al.Efficacy and safety of acarbose chewable tablet in patients with type 2 diabetes: a multicentre, randomized, double-blinded, double-dummy positive controlled trial[J].J Evid Based Med,2012,5(3):134- 138.

引证文献2

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部